Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.
3.
4.
6.

Amtolmetin guacyl versus piroxicam in patients with osteoarthritis.

Montrone F, Santandrea S, Caruso I, Gerli R, Cesarotti ME, Frediani P, Bassani R.

J Int Med Res. 2000 Mar-Apr;28(2):91-100.

PMID:
10898121
8.

Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.

Acevedo E, Castañeda O, Ugaz M, Beaulieu AD, Pons-Estel B, Caeiro F, Casas N, Garza-Elizondo M, Irazoque F, Hinojosa W, Gutierrez-Ureña S, Vandormael K, Rodgers DB, Laurenzi M.

Scand J Rheumatol. 2001;30(1):19-24.

PMID:
11252687
9.

Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.

Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.

Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):378-85.

PMID:
10470596
10.

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.

Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E.

Arch Intern Med. 2000 Jun 26;160(12):1781-7.

PMID:
10871971
11.

Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations.

Baumgartner H, Schwarz HA, Blum W, Bruhin A, Gallachi G, Goldinger G, Saxer M, Trost H.

Curr Med Res Opin. 1996;13(8):435-44.

PMID:
9010610
12.

The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.

Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG; Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.

Arch Intern Med. 2005 Jan 24;165(2):161-8. Erratum in: Arch Intern Med. 2005 Mar 14;165(5):551.

PMID:
15668361
13.

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.

Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, Dixon ME, Polis AB, Mollen AJ, Geba GP; ADVANTAGE Study Group.

Ann Intern Med. 2003 Oct 7;139(7):539-46.

PMID:
14530224
14.
15.

A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain.

Desjardins PJ, Black PM, Daniels S, Bird SR, Fitzgerald BJ, Petruschke RA, Tershakovec A, Chang DJ.

Curr Med Res Opin. 2004 Oct;20(10):1523-37.

PMID:
15462686
17.

A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.

Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE; etoricoxib OA study group.

Curr Med Res Opin. 2003;19(8):725-36. Erratum in: Curr Med Res Opin. 2004 Oct;20(10):1689.

PMID:
14687444
18.

A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.

Bellamy N, Bensen WG, Beaulieu A, Siminovitch KA, Kraag GR, Lussier A, Ahmad S, Khanna VN, Davis P, Bell MJ, et al.

J Rheumatol. 1995 May;22(5):915-20.

PMID:
8587082
19.

A double-blind, placebo controlled comparison of the morphine sparing effect of oral rofecoxib and diclofenac for acute renal colic.

Engeler DS, Ackermann DK, Osterwalder JJ, Keel A, Schmid HP.

J Urol. 2005 Sep;174(3):933-6.

PMID:
16093996
20.

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis.

Truitt KE, Sperling RS, Ettinger WH Jr, Greenwald M, DeTora L, Zeng Q, Bolognese J, Ehrich E; Phase III Rofecoxib Geriatric Study Group.

Aging (Milano). 2001 Apr;13(2):112-21.

PMID:
11405384
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk